Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides
- 16 July 2024
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 54 (4) , 537-556
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibitionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and managementEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Expression of fibroblast activation protein in lung cancer and its correlation with tumor glucose metabolism and histopathologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyondEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Somatostatin receptor imaging with [68Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- 68Ga-FAPI-PET/CT in patients with various gynecological malignanciesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- [153Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020